Therapy Areas: Cardiovascular
17 January 2018 - - Wilmington, Delaware-based AstraZeneca and Kenilworth, New Jersey-based global healthcare solutions provider Merck (NYSE: MRK), known as MSD outside of the United States and Canada...
12 January 2018 - - Marietta, Ohio-based molecular biotechnology company ProtoKinetix, Inc. (OTCQB: PKTX) has entered into a research agreement with The University of British Columbia (UBC), under the...
11 January 2018 - - Thousand Oaks, California-based human therapeutics developer Amgen (NASDAQ: AMGN) and Brussels, Belgium-based biopharmaceutical company UCB's (Euronext Brussels: UCB) marketin...
9 January 2018 - - Jinan, China- and Philadelphia, Pennsylvania-based biotechnology company KBP Biosciences has closed a USD 76m series A financing co-led by Advantech Capital and SDIC Venture Capital...
9 January 2018 - - Shanghai, China-based biopharmaceutical company Jiangsu Hengrui Medicine Co., Ltd. (SSE: 600276) and Menlo Park, California-based biotechnology company Arcutis, Inc. have signed an ...
9 January 2018 - - San Carlos, California-based cardiovascular regenerative therapies developer BioCardia, Inc. (OTC: BCDA) has filed a second investigational device exemption (IDE) with the Food...